PT Suparma Tbk (ISX:SPMA) EBIT : Rp237,116 Mil (TTM As of Sep. 2024)

View and export this data going back to 1994. Start your Free Trial

What is PT Suparma Tbk EBIT?

PT Suparma Tbk's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was Rp90,792 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was Rp237,116 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Suparma Tbk's annualized ROC % for the quarter that ended in Sep. 2024 was 4.22%. PT Suparma Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 13.82%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. PT Suparma Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 19.77%.

PT Suparma Tbk EBIT Historical Data

The historical data trend for PT Suparma Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Suparma Tbk EBIT Chart

PT Suparma Tbk Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

223,669.02

228,814.61

408,620.97

463,862.34

272,479.36

PT Suparma Tbk Quarterly Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial											38,739.61	64,135.16	40,205.81	41,983.04	90,791.87

Competitive Comparison of PT Suparma Tbk's EBIT

For the Paper & Paper Products subindustry, PT Suparma Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Suparma Tbk's EV-to-EBIT Distribution in the Forest Products Industry

For the Forest Products industry and Basic Materials sector, PT Suparma Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Suparma Tbk's EV-to-EBIT falls into.

PT Suparma Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp237,116 Mil.

PT Suparma Tbk (ISX:SPMA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Suparma Tbk's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	159842.32 * ( 1 - 21.82% )	/	( (2910890.591	+	3018621)	/ 2 )
=	124964.725776	/	2964755.7955
=	4.22 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3401240.177	-	127991.929	-	( 362357.657	-	max(0, 524813.938	-	1469344.279	+	362357.657	))
=	2910890.591

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3330426.153	-	122348.905	-	( 189456.248	-	max(0, 449306.568	-	1393869.995	+	189456.248	))
=	3018621

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Suparma Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	363167.468	/	( ( (1604786.282 + max(972896.81, 0))	+	(1602359.843 + max(1074527.209, 0)) )	/	2 )
=	363167.468	/	( ( 2577683.092	+	2676887.052 )	/	2 )
=	363167.468	/	2627285.072
=	13.82 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(196648.872	+	885403	+	21595.38)	-	(127991.929	+	0	+	2758.513)
=	972896.81

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(198479.838	+	978460.706	+	23987.602)	-	(122348.905	+	0	+	4052.0320000001)
=	1074527.209

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Suparma Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	237115.879	/	1199495.359
	=	19.77 %

PT Suparma Tbk EBIT Related Terms

Thank you for viewing the detailed overview of PT Suparma Tbk's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Suparma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » PT Suparma Tbk (ISX:SPMA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Raya Mastrip No. 856, Warugunung, Karangpilang, East Java, Surabaya, IDN, 60221

Website

https://www.ptsuparmatbk.com

PT Suparma Tbk is an Indonesia-based company that operates in the paper and paper product business. The primary activity of the group includes manufacturing paper and paper wrapping products for industrial and consumer sectors. Its products offered the firm are duplex board, wrapping kraft, ribbed kraft, laminated kraft, Samson kraft, printing paper, tissue paper, and towel paper.

PT Suparma Tbk Headlines

No Headlines